What are the perils and pitfalls of going international? Operators discuss international M&A and greenfield site challenges.
Building an international hospital group ► Dr Azad Moopen, Founder Chairman & Managing Director, Aster DM Healthcare
Over 30 years Dr Moopen has built Aster DM from scratch into one of the largest groups in the GCC and India, moving into hospitals, pharmacies, diagnostics and outpatient. He talks about the challenges and lessons of the last five years as the group has expanded internationally and reflects on future business models and markets ahead of the group's listing on the Mumbai stock exchange.
American Academic Medical Centers Involvement In Foreign Markets is a Multi-Billion Dollar Business ► Juan Carlos Negrette, Director, Global Health at University of Utah - Health Sciences
Mayo, Johns Hopkins, Cleveland, UPMC and Texas Medical Centers have built huge revenue streams from patient referrals and affiliation programmes. Juan Carlos, formerly managing director at Johns Hopkins International, presents recent research including his estimates of revenue flows by group and dissects the business models, successful and unsuccessful, that they have deployed. What are the lessons for other players?
Lessons on healthcare from Falck ► Jan F Steenhard, CEO, Healthcare, Falck
Falck is the quiet giant of healthcare running ambulance services, clinics, primary care, rehab and subscription services across 3 continents and 40 countries with over €1.5bn in health care revenue. Here, Jan unpackages some of its surprising business models, such as subscription healthcare sold to 1m individuals in Latam and 300,000 in the Nordic. How does it incentivise entrepreneurs who sell their businesses to Falck. What has Falck learnt from its international expansion and where does it see opportunities?